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Vascular manifestations are the primary clinical feature
of patients with Behçet’s disease. Venous manifestations
are more common than arterial involvement, with superfi-
cial thrombophlebitis having been reported in 12% to 27%
of patients.1 Of surgical interest are the arterial manifesta-
tions; aneurysms and arterial thrombosis have been
reported in 5% to 35% of patients.2,3 Arterial manifesta-
tions carry a poor prognosis, because of the propensity for
aneurysms to rupture, especially pulmonary artery
aneurysms.3 Management of peripheral arterial complica-
tions is especially problematic. Despite close duplex scan
graft surveillance, bypass grafts are associated with a sig-
nificant incidence of thrombosis or anastomotic aneurys-
mal degeneration.4,5 The use of covered stent grafts to
exclude the aneurysms may provide better long-term
patency. We herein describe a patient successfully treated
with a saphenous vein–covered stent introduced through
a proximal surgical cut-down.
CASE REPORT
A 29-year old African American man was maintained on war-
farin for previous episodes of recurrent superficial and deep
venous thrombosis. A complete hypercoagulation panel was
inconclusive. The patient presented to the emergency department
with a sudden onset of massive swelling of his left thigh. No his-
tory of recent or remote trauma, drug abuse, or infective endo-
carditis was elicited. On physical examination he was
normotensive and afebrile and had a heart rate of 98 beats per
minute. A massive and tense swelling of the anteriomedial com-
partment of the left thigh was observed with an obvious bruit.
Dorsalis pedis and posterior tibial pulses were 1+ compared with
4+ on the contralateral unaffected extremity. Laboratory investi-
gations showed a normal white cell count, hemoglobin of 8.9
g/dL, and an erythrocyte sedimentation rate of 82 mm per hour.
A diagnostic angiogram was performed via the contralateral
femoral artery using a crossover technique. A ruptured aneurysm
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of the superficial femoral artery was seen with active contrast
extravasation (Fig 1). On further questioning, the patient
reported a history of recurrent oral ulcers and skin nodules over
both legs highly suggestive of erythema nodosum. A left femoral
cut-down was performed through a transverse groin incision.
Proximal and distal control of the common femoral artery (CFA)
was obtained, and an 18-gauge Potts needle introduced ante-
grade into the CFA. The needle was then replaced with a 5F
catheter sheath exchanged over a 0.035-in guidewire. Contrast
injected through the 5F catheter sheath was used to accurately
identify the neck of the aneurysm. A Palmaz 406B (Cordis Corp,
Miami, Fla) stent was mounted on a 6-mm × 4-cm Marshal
(Boston Scientific Corp, Natick, Mass) balloon and passed
through a short segment of greater saphenous vein excised from
the contralateral leg. The balloon was then inflated ex vivo and
subsequently deflated. The saphenous vein thus mounted on the
Palmaz stent was secured to the stent by multiple 6-0 prolene
sutures. The covered stent graft was then recrimpled over the 6 ×
4 angioplasty balloon. Two hundred micrograms of nitroglycer-
ine were then instilled through the 5F catheter sheath and the
sheath withdrawn, leaving the guidewire in place. Then, using
vessel loops to control the CFA, a transverse arteriotomy was
made in the CFA, and the vein-covered stent was introduced into
the superficial femoral artery over the 0.035 guidewire. The cov-
ered stent was accurately deployed over the neck of the aneurysm
using road-mapping techniques. A completion angiogram (Fig 2)
demonstrated aneurysm exclusion without contrast extravasation.
The guidewire and balloon were then withdrawn and the arteri-
otomy closed with interrupted 6-0 prolene. A 5-cm longitudinal
incision was subsequently made over the medial aspect of the
thigh to drain the hematoma. Transthoracic echocardiogram,
blood, and wound cultures were negative. The patient was dis-
charged on the sixth postoperative day on oral corticosteroids,
warfarin, and aspirin.
At the 1-month follow-up a sterile seroma was drained from
the previous site of the hematoma evacuation. Duplex ultrasound
scanning at 9 months revealed a patent stent-graft with normal
flow velocity and an ankle-brachial index of 0.98 on the ipsilateral
limb and 1.02 on the contralateral limb. Duplex scanning of both
CFAs did not reveal a pseudoaneurysm at the site of arterial entry.
Computed tomogram of the chest and abdomen to evaluate for
other arterial aneurysms revealed a pulmonary artery aneurysm
that was successfully coil-embolized.
DISCUSSION
In 1937, Behçet described the triad of relapsing irido-
cyclitis and orogenital ulcers that now bears his name.6 It
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is now recognized as a chronic multisystem relapsing
inflammatory syndrome secondary to small vessel vasculi-
tis.7 The lack of a single diagnostic test makes the diagno-
sis of Behçet’s disease difficult despite a new set of criteria
proposed by the international study group for Behçet’s dis-
ease (Table I).8 Arterial involvement can be either occlusive
or aneurysmal degeneration. Arterial aneurysms, although
rare, are more frequently reported compared with occlu-
sions. In a review of 868 patients over a 40-year period,
only 22 cases with arterial occlusion were recorded.9 The
abdominal aorta and the pulmonary artery are the two
most frequently reported sites of aneurysmal degenera-
tion.10
The pathogenesis of aneurysmal degeneration is
thought to be vasculitis resulting in obliterative endarteri-
tis of the vasa vasorum supplying the medium-sized and
large-sized vessels.11 Interestingly, Behçet’s disease is the
only systemic vasculitis associated with pulmonary artery
aneurysms.12 Although aneurysms are not common in
Behçet’s disease, they are a major cause of death secondary
to rupture. Hence surgical treatment of diagnosed
aneurysms is mandatory. Unfortunately, surgical bypass
sites and sites of arterial puncture are frequently the sites
for new aneurysmal degeneration or occlusion.5,11,13-15
However, when open surgical therapy was required,
aneurysmectomy with direct closure of the aneurysmal
defect has been reported to have better long-term
patency.11
Although covered stents have been used to treat
extremity pseudoaneurysms since first described by Becker
et al in 1991,16 no report on the use of covered stents in
patients with Behçet’s disease was found in a literature
search. Unfortunately, long-term follow-up in most clini-
cal reports for use of covered stents is limited, the longest
follow-up being 14 months.17 However, complications
related to the use of covered stents for this limited follow-
up are few. Two isolated case reports include one stent
infection in a hemodialysis patient and an extrinsic com-
pression of a balloon-expandable stent placed at the base
of the skull for a carotid pseudoaneurysm.18,19
Minimal arterial trauma to the site of aneurysm degen-
eration may prevent further vascular degeneration. Based
Table I. The International Study Group criteria for diagnosis of Behçet’s disease
Features present 
Diagnostic criteria Definition in case report
Recurrent oral ulceration Minor/major aphthous ulceration that recurred ≥3 times in a 12-mo period Yes
Plus 2 of:
Recurrent genital ulceration Aphthous ulceration or scarring Yes
Eye lesions Uveitis or retinal vasculitis No
Skin lesions Erythema nodosum, pseudofolliculitis, or papulopustular lesions Yes
Pathergy test Read in 24-48 h Yes
Fig 1. Diagnostic angiogram demonstrating the ruptured super-
ficial femoral artery aneurysm.
Fig 2. Exclusion of aneurysm with a vein-covered Palmaz stent.
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on a literature review4,5,11,20-25 (Table II) of the 10
reported infrainguinal arterial aneurysms treated with
bypass grafts in patients with Behçet’s disease, the mean
time to aneurysm formation at the anastomotic sites was
3.3 months, with the longest primary patency noted at 6
months.11 Similarly, the time to graft occlusion was an
average of 8.3 months, with the longest reported patency
being 16 months.11 In our patient, a remote site surgical
access and avoidance of direct operative manipulation at
the site of aneurysmal degeneration may be responsible for
the favorable outcome, currently at 9 months after the
procedure.
In conclusion, a single case report cannot prompt a
treatment recommendation even in rare diseases.
However, endovascular options are an attractive alterna-
tive for the management of peripheral aneurysms in
patients with Behçet’s disease.
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Table II. Case reports of peripheral arterial aneurysms in patients with Behçet’s disease
Author Location Type Management Follow-up (event in months)
Enoch et al (1968)5 Popliteal True Graft Thrombosis, anastomotic aneurysm
Jenkins et al (1976)4 Common femoral True Graft (terylene) Aneurysm (2), thrombosis (9)
Superficial femoral True Graft (vein) Aneurysm (2), thrombosis (4)
Freyrie et al (1993)11 Common femoral True Graft (Dacron) Aneurysm (6, 12), occlusion (16)
Crick (1963)20 Femoral True N/A N/A
Schwartz et al (1987)21 Common femoral True Graft (ePTFE) Aneurysm (3, 4), thrombosis (4, 6)
Shimizu et al (1979)22 Femoral True N/A N/A
Reza et al (1978)23 Femoral True N/A N/A
Chamberlain (1977)24 Popliteal True N/A N/A
Piers (1977)25 Popliteal True Medical Thrombosis of aneurysm
N/A, Not applicable.
